BackArriVent BioPharma Overview

ArriVent BioPharma Current Cash

Latest current cash for AVBP: $62M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$62.10M
↑ 24.54% YoYΔ $12.24M vs prior year quarter

Peer average

Loading

ArriVent BioPharma Current Cash History

Loading

ArriVent BioPharma vs. peers: Current Cash Comparison

Loading

ArriVent BioPharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ArriVent BioPharma (AVBP) FAQ

ArriVent BioPharma (AVBP) currently reports a current cash of $62M as of March 2026. That compares with $50M in the prior-year period — up 24.5% year over year. Use the charts on this page to explore ArriVent BioPharma's current cash history and peer comparisons.

ArriVent BioPharma's current cash increased from $50M to $62M — a 24.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ArriVent BioPharma reported $62M in current cash as of March 2026. That compares with $50M in the prior-year period — up 24.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $62M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ArriVent BioPharma, and consider following AVBP for alerts when major investors trade the stock.